Viral Genome Sequencing Market Report 2026

Viral Genome Sequencing Market Overview

• Viral Genome Sequencing market size has reached to $6.71 billion in 2025 • Expected to grow to $13.57 billion in 2030 at a compound annual growth rate (CAGR) of 15.1% • Growth Driver: Surge In Increasing Prevalence Of Infectious Diseases Fueling The Growth Of The Market Due To Higher Demand For Rapid Pathogen Surveillance • Market Trend: Advances in Long-Read Sequencing Technologies Enhancing Viral Genome Analysis • Asia-Pacific was the largest region and fastest growing region.

What Is Covered Under Viral Genome Sequencing Market?

Viral genome sequencing is the laboratory process of determining the complete nucleotide sequence of a virus’s genetic material, whether DNA or RNA. This technique allows scientists to read the virus’s entire genetic code, making it possible to identify the virus, study its structure and function, detect mutations, and monitor genetic changes over time. The main sequencing technologies of viral genome sequencing include next-generation sequencing, Sanger sequencing, and third-generation sequencing. Next-generation sequencing allows rapid and high-throughput analysis of viral genomes to detect mutations, track outbreaks, and support public health responses. They are used with sample types such as blood, nasal or throat swabs, saliva, and other sample types. They are applied in clinical diagnostics, research, epidemiology, vaccine development, and other applications, while the end-use includes hospitals and clinics, research institutes, pharmaceutical and biotechnology companies, and other end-users.

What Is The Viral Genome Sequencing Market Growth Forecast?

The viral genome sequencing market size is expected to see rapid growth in the next few years. It will grow to $13.57 billion in 2030 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to ai-driven genome analysis, expansion of vaccine development programs, adoption of portable sequencing technologies, integration with predictive bioinformatics, increasing focus on real-time pathogen monitoring. Major trends in the forecast period include high-throughput viral genome sequencing, portable sequencing devices, integration with bioinformatics platforms, automated sample processing, real-time mutation tracking.

Global Viral Genome Sequencing Market Segmentation

1) By Sequencing Technology: Next-Generation Sequencing, Sanger Sequencing, Third-Generation Sequencing 2) By Sample Type: Blood, Nasal Or Throat Swabs, Saliva, Other Sample Types 3) By Application: Clinical Diagnostics, Research, Epidemiology, Vaccine Development, Other Applications 4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users Subsegments: 1) By Next-Generation Sequencing: Sequencing By Synthesis, Ion Semiconductor Sequencing, Reversible Terminator Chemistry Sequencing, Targeted Amplicon Sequencing, Whole Genome Shotgun Sequencing 2) By Sanger Sequencing: Capillary Electrophoresis Sequencing, Automated Fluorescent Chain Termination Sequencing, Dideoxy Chain Termination Sequencing, Low Throughput Mutation Verification Sequencing, Plasmid Insert Verification Sequencing 3) By Third-Generation Sequencing: Single Molecule Real Time Sequencing, Nanopore Based Sequencing, Zero Mode Waveguide Sequencing, Long Read Direct Ribonucleic Acid Sequencing, Real Time Field Deployable Sequencing

What Is The Driver Of The Viral Genome Sequencing Market?

The increasing prevalence of infectious diseases is expected to propel the growth of the viral genome sequencing market going forward. Infectious diseases are caused by pathogenic microorganisms and continue to rise globally due to factors such as increased international travel, urbanization, and rapid cross-border transmission of pathogens. This growing disease burden has led governments and healthcare systems to strengthen genomic surveillance and outbreak response capabilities. Viral genome sequencing plays a critical role in controlling infectious diseases by enabling rapid identification of viral strains, monitoring mutations, tracking transmission pathways, and supporting targeted public health interventions. For instance, in February 2026, according to the Centers for Disease Control and Prevention (CDC), a US-based government department, in 2026, influenza resulted in approximately 290,000–450,000 hospitalizations and 34,000–53,000 deaths annually in the United States, while RSV accounted for an estimated 190,000–350,000 hospitalizations and 10,000–23,000 deaths. Therefore, an increasing prevalence of infectious diseases is expected to drive the growth of the viral genome sequencing industry.

Key Players In The Global Viral Genome Sequencing Market

Major companies operating in the viral genome sequencing market are F. Hoffmann‑La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio‑Rad Laboratories Inc., QIAGEN N.V., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Novogene Co. Ltd., Takara Bio Inc., Twist Bioscience Corporation, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Genewiz, Macrogen Inc., MedGenome Labs Ltd., Eurofins Scientific SE, CD Genomics, BGI Genomics Co. Ltd.

Global Viral Genome Sequencing Market Trends and Insights

Major companies operating in the viral genome sequencing market are focusing on technological advancement in long-read sequencing, such as benchtop long-read sequencing platforms, to gain a competitive advantage. A benchtop long-read sequencing platform is an integrated laboratory system designed to generate highly accurate, extended nucleotide reads from viral genomes within a compact footprint, enabling comprehensive structural variant detection, improved genome assembly, and faster turnaround for pathogen characterization, strengthening surveillance capabilities, supporting outbreak response, and enhancing research precision while requiring higher capital investment and advanced data analysis infrastructure at scale. For instance, in November 2024, Pacific Biosciences, a US-based biotechnology company, introduced the Revio benchtop HiFi sequencing platform. The platform delivers high-fidelity long reads, increased throughput compared with earlier systems, and scalable configuration for clinical and research laboratories, improving viral mutation tracking and genome completeness in the viral genome sequencing market.

What Are Latest Mergers And Acquisitions In The Viral Genome Sequencing Market?

In February 2025, Deerfield Management Company, a U.S.-based investment management firm focused on healthcare innovation, acquired Singular Genomics Systems for an undisclosed amount. With this acquisition, Deerfield aims to provide Singular Genomics with greater strategic flexibility to advance its next-generation sequencing and spatial multiomics technologies for researchers and clinicians. Singular Genomics is a U.S.-based provider of NGS platforms, including the G4 sequencing platform for genomic sequencing and the developing G4x spatial sequencer for multiomics applications.

Regional Insights

North America was the largest region in the viral genome sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Viral Genome Sequencing Market?

The viral genome sequencing market includes revenues earned by providing services such as whole viral genome sequencing, targeted amplicon sequencing, metagenomic sequencing for pathogen discovery, viral variant analysis and mutation profiling, and bioinformatics data interpretation and phylogenetic analysis services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Viral Genome Sequencing Market Report 2026?

The viral genome sequencing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the viral genome sequencing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.